Literature DB >> 12142343

Sphingosylphosphorylcholine is a novel messenger for Rho-kinase-mediated Ca2+ sensitization in the bovine cerebral artery: unimportant role for protein kinase C.

Satoshi Shirao1, Shiro Kashiwagi, Masafumi Sato, Saori Miwa, Fumiaki Nakao, Tetsu Kurokawa, Natsuko Todoroki-Ikeda, Kimiko Mogami, Yoichi Mizukami, Shinichi Kuriyama, Kyousuke Haze, Michiyasu Suzuki, Sei Kobayashi.   

Abstract

Although recent investigations have suggested that a Rho-kinase-mediated Ca2+ sensitization of vascular smooth muscle contraction plays a critical role in the pathogenesis of cerebral and coronary vasospasm, the upstream of this signal transduction has not been elucidated. In addition, the involvement of protein kinase C (PKC) may also be related to cerebral vasospasm. We recently reported that sphingosylphosphorylcholine (SPC), a sphingolipid, induces Rho-kinase-mediated Ca2+ sensitization in pig coronary arteries. The purpose of this present study was to examine the possible mediation of SPC in Ca2+ sensitization of the bovine middle cerebral artery (MCA) and the relation to signal transduction pathways mediated by Rho-kinase and PKC. In intact MCA, SPC induced a concentration-dependent (EC50=3.0 micromol/L) contraction, without [Ca2+]i elevation. In membrane-permeabilized MCA, SPC induced Ca2+ sensitization even in the absence of added GTP, which is required for activation of G-proteins coupled to membrane receptors. The SPC-induced Ca2+ sensitization was blocked by a Rho-kinase inhibitor (Y-27632) and a dominant-negative Rho-kinase, but not by a pseudosubstrate peptide for conventional PKC, which abolished the Ca2+-independent contraction induced by phorbol ester. In contrast, phorbol ester-induced Ca2+ sensitization was resistant to a Rho-kinase inhibitor and a dominant-negative Rho-kinase. In primary cultured vascular smooth muscle cells, SPC induced the translocation of cytosolic Rho-kinase to the cell membrane. We propose that SPC is a novel messenger for Rho-kinase-mediated Ca2+ sensitization of cerebral arterial smooth muscle and, therefore, may play a pivotal role in the pathogenesis of abnormal contraction of the cerebral artery such as vasospasm. The SPC/Rho-kinase pathway functions independently of the PKC pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12142343     DOI: 10.1161/01.res.0000026057.13161.42

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  40 in total

Review 1.  Role of rho kinase in the functional and dysfunctional tonic smooth muscles.

Authors:  Márcio A F de Godoy; Satish Rattan
Journal:  Trends Pharmacol Sci       Date:  2011-04-15       Impact factor: 14.819

Review 2.  Cellular and molecular mechanisms regulating vascular tone. Part 2: regulatory mechanisms modulating Ca2+ mobilization and/or myofilament Ca2+ sensitivity in vascular smooth muscle cells.

Authors:  Takashi Akata
Journal:  J Anesth       Date:  2007-05-30       Impact factor: 2.078

Review 3.  ROCK and Rho: biochemistry and neuronal functions of Rho-associated protein kinases.

Authors:  André Schmandke; Antonio Schmandke; Stephen M Strittmatter
Journal:  Neuroscientist       Date:  2007-10       Impact factor: 7.519

Review 4.  Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.

Authors:  Jianjian Shi; Lei Wei
Journal:  J Cardiovasc Pharmacol       Date:  2013-10       Impact factor: 3.105

5.  Sphingosylphosphorylcholine activates dendritic cells, stimulating the production of interleukin-12.

Authors:  Ana Ceballos; Juan Sabatté; Karen Nahmod; Diego Martínez; Gabriela Salamone; Mónica Vermeulen; Julián Maggini; Horacio Salomón; Jorge Geffner
Journal:  Immunology       Date:  2007-03-20       Impact factor: 7.397

Review 6.  Rho kinase as a therapeutic target in cardiovascular disease.

Authors:  Michelle Surma; Lei Wei; Jianjian Shi
Journal:  Future Cardiol       Date:  2011-09

7.  Human vascular endothelial cells reduce sphingosylphosphorylcholine-induced smooth muscle cell contraction in co-culture system through integrin β4 and Fyn.

Authors:  Di Ge; Ning Meng; Le Su; Yun Zhang; Shang-li Zhang; Jun-ying Miao; Jing Zhao
Journal:  Acta Pharmacol Sin       Date:  2011-12-05       Impact factor: 6.150

Review 8.  The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction.

Authors:  Karl Swärd; Mitsuo Mita; David P Wilson; Jing Ti Deng; Marija Susnjar; Michael P Walsh
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

9.  Cholesterol Perturbation in Mice Results in p53 Degradation and Axonal Pathology through p38 MAPK and Mdm2 Activation.

Authors:  Qingyu Qin; Guanghong Liao; Michel Baudry; Xiaoning Bi
Journal:  PLoS One       Date:  2010-04-06       Impact factor: 3.240

10.  Signaling through Rho GTPase pathway as viable drug target.

Authors:  Qun Lu; Frank M Longo; Huchen Zhou; Stephen M Massa; Yan-Hua Chen
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.